Epidermal Growth Factor Receptor Activity Determines Response of Colorectal Cancer Cells to Gefitinib Alone and in Combination With Chemotherapy
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-05-0328
Full Text
Open PDFAbstract
Available in full text
Date
October 15, 2005
Authors
Publisher
American Association for Cancer Research (AACR)